OCUGEN, INC. Shares Issued
OCUGEN, INC. (OCGN) had Shares Issued of 339.17 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-06
- 2026-06-30: Common Stock, Shares, Issued 339.17M shares.
- 2026-03-31: Common Stock, Shares, Issued 338.44M shares.
- 2025-12-31: Common Stock, Shares, Issued 312.50M shares.
- 2025-09-30: Common Stock, Shares, Issued 312.44M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 339.17M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 338.44M shares 10-Q · filed 2026-05-08 | |
| 2025-12-31 | 312.50M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 312.44M shares 10-Q · filed 2025-11-05 | |
| 2025-06-30 | 292.31M shares 10-Q · filed 2025-08-04 | |
| 2025-03-31 | 292.15M shares 10-Q · filed 2025-05-09 | |
| 2024-12-31 | 291.49M shares 10-K · filed 2026-03-04 | |
| 2024-09-30 | 290.38M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 257.54M shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 257.45M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 256.69M shares 10-K · filed 2025-03-05 | |
| 2023-09-30 | 256.62M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 256.61M shares 10-Q · filed 2023-08-21 | |
| 2023-03-31 | 226.55M shares 10-Q · filed 2023-05-05 | |
| 2022-12-31 | 221.72M shares 10-K · filed 2024-04-16 | |
| 2022-09-30 | 216.81M shares 10-Q · filed 2022-11-08 | |
| 2022-06-30 | 216.27M shares 10-Q · filed 2022-08-05 | |
| 2022-03-31 | 215.75M shares 10-Q · filed 2022-05-06 | |
| 2021-12-31 | 199.50M shares 10-K · filed 2023-02-28 | |
| 2021-09-30 | 199.05M shares 10-Q · filed 2021-11-09 | |
| 2021-06-30 | 198.82M shares 10-Q · filed 2021-08-06 | |
| 2021-03-31 | 188.28M shares 10-Q · filed 2021-05-07 | |
| 2020-12-31 | 184.13M shares 10-K · filed 2022-02-28 | |
| 2020-09-30 | 162.15M shares 10-Q · filed 2020-11-06 | |
| 2020-06-30 | 135.13M shares 10-Q · filed 2020-08-14 | |
| 2020-03-31 | 52.75M shares 10-Q · filed 2020-05-08 | |
| 2019-12-31 | 52.75M shares 10-K · filed 2021-03-19 | |
| 2019-09-30 | 10.01M shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 13.02M shares 8-K/A · filed 2019-10-07 | 94.60M shares 10-Q · filed 2019-08-09 |
| 2019-03-31 | 94.60M shares 10-Q · filed 2019-05-15 | |
| 2018-12-31 | 4.96M shares 10-K · filed 2020-03-27 | 62.03M shares 10-K · filed 2019-03-22 |
| 2018-09-30 | 35.00M shares 10-Q · filed 2018-11-08 | |
| 2018-06-30 | 28.79M shares 10-Q · filed 2018-08-09 | |
| 2018-03-31 | 28.69M shares 10-Q · filed 2018-05-10 | |
| 2017-12-31 | 24.57M shares 10-K · filed 2019-03-22 | |
| 2017-09-30 | 22.79M shares 10-Q · filed 2017-11-09 | |
| 2017-06-30 | 22.28M shares 10-Q · filed 2017-08-10 | |
| 2017-03-31 | 22.17M shares 10-Q · filed 2017-05-11 | |
| 2016-12-31 | 20.65M shares 10-K · filed 2018-03-15 | |
| 2016-09-30 | 15.87M shares 10-Q · filed 2016-11-10 | |
| 2016-06-30 | 13.27M shares 10-Q · filed 2016-08-11 | |
| 2016-03-31 | 13.27M shares 10-Q · filed 2016-05-12 | |
| 2015-12-31 | 13.27M shares 10-K · filed 2017-03-16 | |
| 2015-09-30 | 13.27M shares 10-Q · filed 2015-11-12 | |
| 2015-06-30 | 13.24M shares 10-Q · filed 2015-08-12 | |
| 2015-03-31 | 13.22M shares 10-Q · filed 2015-05-14 | |
| 2014-12-31 | 12.76M shares 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |